Back to the main directory
EarningsReview / Equity
- Lower TP and EPS, removing Cook contribution by BNP Paribas Exane
- F4Q23 Quick Take by BNP Paribas Exane
- Conclusions after nine stops in Sweden by BNP Paribas Exane
- Notes from Boston by BNP Paribas Exane
- Europris (Buy, TP: NOK85.00) - Still outperforming in tough market by DnB Markets
- Crayon (Hold, TP: NOK110.00) - Mixed Q1 leaves uncertainty by DnB Markets
- HMS Networks (Hold, TP: SEK515.00) - Continued strong backlog execution by DnB Markets
- NII set to decline (but that’s ok) by DnB Markets
- INDITEX: RDOS. 1T’23 (ANÁLISIS BANCO SABADELL) by Sabadell
- Hiwin (2049 TT) by HSBC
- INVEST SECURITIES - BIOPHYTIS : Dossier soumis à la HAS pour une AAP, verdict au T3 23 - NEUTRE, OC 0,05€ by Invest Securities
- Moving beyond pilot stage with Europe''s 4th water co. by BNP Paribas Exane
- Claranova - Potential sale of non-core Avanquest activities by Edison Investment Research
- Orkla (Hold, TP: NOK80.00) - H2 likely to be highlight of Q2 by DnB Markets
- Kongsberg Gruppen (Buy, TP: NOK550.00) - Well positioned for the arms race by DnB Markets
- Viaplay Group (Hold, TP: SEK70.00) - Too many bold ambitions by DnB Markets
- Supplying Concerns by BNP Paribas Exane
- INVEST SECURITIES - ATOS : Les avancées de Tech Foundations occultées - ACHAT, OC 18€ by Invest Securities
- WOOD Flash: Wizz Air: 4Q FY23 – miss vs. consensus on higher opex, forward-looking guidance implies upside by Wood and Company
- Inditex (ITX SM) by HSBC
- Puuilo - The best discount retailer in Finland by Danske Bank Equity Research
- BNPPE Aesthetics Day: Four perspectives by BNP Paribas Exane
- Ultimovacs (Buy, TP: NOK200.00) - Topline results for NIPU trial by DnB Markets
- SalMar (Buy, TP: NOK565.00) - Divesting Frøy by DnB Markets
- Arjo (Buy, TP: SEK55.00) - Q1 trends to continue in Q2e by DnB Markets